Mystic Pharmaceuticals has received notices of allowance from the China Patent Office and the Japan Patent Office for its 'Deep Draw Container Forming Method' and 'Combination Unit Dose Dispensing Container' patent applications ...
Tags: Drug Delivery Platforms, Medicine
US-based biotechnology firm BioTime has entered into a sublicense agreement with Jade Therapeutics, a developer of ophthalmic sustained-release drug delivery platforms, for ophthalmic drug delivery applications of BioTime's HyStem ...
Tags: Health, Medicine, biotechnology
US-based Mystic Pharmaceuticals has secured two Notices of Allowance from the US Patent Office for its Unit Dose Drug Delivery Platform and Piercing Device for Drug Delivery Systems patent applications. According to the company, the new ...
Pulmatrix, a developer of inhalable drug delivery platforms, has appointed Robert Clarke as the company's new chief executive officer (CEO). Previously, Clarke served as the company's chief scientific officer and vice president of ...